CNY 44.86
−6.50%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 43.67
From 52W high−12.30%
Volume53.44M
Market capCNY 82.42B
P/E (TTM)49.5x
P/S (TTM)5.5x
Div yield0.46%
Key dataSep 18, 2026
Open
CNY 43.67
From 52W high
−12.30%
Volume
53.44M
Market cap
CNY 82.42B
ValuationView details →
P/E (Fwd)
29.1x
EV/EBITDA
26.7x
P/E (TTM)
49.5x
RSI (14)
51.8
MomentumView details →
1D Return
−6.50%
YTD Return
+52.30%
Similar companies
Latest newsMore news →
Pharmaceutical R&D service company Pharmaron (03759) announced the proposed issuance of RMB 2.18 billion zero-coupon convertible bonds due 2027, priced at 102% of principal, with net proceeds of approximately USD 327.2 million to be used for business expansion, debt refinancing, and general corporate purposes.25d agoAI² Robotics and Pharmaron signed a strategic partnership agreement to combine AI² Robotics' embodied large model technology with Pharmaron's life sciences expertise, focusing on deploying embodied intelligence in pharmaceutical R&D and building smart lab ecosystems.25d ago